Provided by Tiger Trade Technology Pte. Ltd.

Roche Holding Ltd

483.97
0.0000
Volume:- -
Turnover:- -
Market Cap:385.24B
PE:- -
High:483.97
Open:483.97
Low:483.97
Close:483.97
52wk High:500.01
52wk Low:288.90
Shares:796.00M
Float Shares:727.01M
Volume Ratio:0.66
T/O Rate:- -
Dividend:12.69
Dividend Rate:2.62%
ROE:37.27%
ROA:12.94%
PB:8.80
PE(LYR):- -

Loading ...

Company Profile

Company Name:
Roche Holding Ltd
Exchange:
OTCQX
Establishment Date:
1896
Employees:
103249
Office Location:
Grenzacherstrasse 124,Basel,Basel-Stadt,Switzerland
Zip Code:
4070
Fax:
41 61 691 00 14
Introduction:
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.